As winter arrives, the stark shift to dry air and central heating presents a challenge for those with eczema and psoriasis.
An international team of investigators has reported results from the first Phase III clinical trials of rocatinlimab, a novel treatment for moderate-to-severe atopic dermatitis (eczema).